A MULTI - CENTER OPEN LABEL PHASE II (B) STUDY TO ASSESS EFFECTS OF SOM230 ON CARDIOVASCULAR PARAMETERS IN ACROMEGALIC PATIENTS
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Pasireotide (Primary)
- Indications Acromegaly
- Focus Therapeutic Use
- 27 Sep 2016 New trial record